Literature DB >> 14755315

Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes.

K-H Lee1, J-H Lee, S-J Choi, J-H Lee, S Kim, M Seol, Y-S Lee, W-K Kim, J-S Lee.   

Abstract

The outcomes of patients who experience the failure to reconstitute a trilineage of blood cells after initial neutrophil engraftment were evaluated in 178 patients with hematologic disorders, who underwent allogeneic HCT. Of 165 qualified patients (five with primary engraftment failure; eight deaths before day 60 of HCT), 43 (26%) satisfied the criteria for the initial (n=22; failure of platelet >20 000/microl or red blood cell transfusion independence/reticulocyte count >/=1.0% by day 60) or subsequent (n=21, ANC <500/microl for >/=3 days, platelet <20 000/microl for >/=7 days, or red blood cells transfusion/reticulocyte <1.0% after initial trilineage reconstitution) failure. GVHD was the most common clinical condition associated with cytopenia (n=24). In all, 20 patients (47%) recovered at least partially with a median of 52 days (range 8-323) later, with 12 of those 20 patients recovering completely. The eventual reconstitution failure rate was 14% (23/163 patients). The number of cell lineages involved in the cytopenia was the only independent variable that predicted partial recovery (1 lineage vs 2-3 lineages with odds ratio of 8.69 (95% CI 1.96-38.60), P=0.004). Five/20 patients with vs 20/23 patients without partial recovery died. Trilineage reconstitution failures after allogeneic HCT need systematic analysis in the future studies.

Entities:  

Mesh:

Year:  2004        PMID: 14755315     DOI: 10.1038/sj.bmt.1704428

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  12 in total

Review 1.  Eltrombopag: Role in Cytopenias Following Hematopoietic Stem Cell Transplantation.

Authors:  Ram Vasudevan Nampoothiri; Rajat Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-24       Impact factor: 0.900

2.  Mitochondrial reactive oxygen species regulate adipocyte differentiation of mesenchymal stem cells in hematopoietic stress induced by arabinosylcytosine.

Authors:  Weimin Wang; Yao Zhang; Wenyi Lu; Kaiyan Liu
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

3.  [Risk-factors analysis of graft failure after allogeneic hematopoietic stem cell transplantation].

Authors:  Y Fei; X X Hu; Q Chen; A J Huang; H Cheng; X Ni; L Chen; L Gao; G S Tang; J Chen; W P Zhang; J M Yang; J M Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

4.  Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Authors:  Cen Tang; Feng Chen; Danqing Kong; Qinfen Ma; Haiping Dai; Jia Yin; Zheng Li; Jia Chen; Xiaming Zhu; Xinliang Mao; Depei Wu; Xiaowen Tang
Journal:  J Hematol Oncol       Date:  2018-08-16       Impact factor: 17.388

5.  Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective study.

Authors:  Wei-Ran Lv; Ya Zhou; Jun Xu; Zhi-Ping Fan; Fen Huang; Na Xu; Li Xuan; Peng-Cheng Shi; Hui Liu; Zhi-Xiang Wang; Jing Sun; Qi-Fa Liu
Journal:  Cancer Med       Date:  2021-10-20       Impact factor: 4.452

6.  Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients.

Authors:  Hyun Jin Ahn; Ja Min Byun; Inho Kim; Jeonghwan Youk; Youngil Koh; Dong-Yeop Shin; Junshik Hong; Sung-Soo Yoon
Journal:  J Korean Med Sci       Date:  2022-02-14       Impact factor: 2.153

Review 7.  Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.

Authors:  Ashvind Prabahran; Rachel Koldej; Lynette Chee; David Ritchie
Journal:  Blood Adv       Date:  2022-03-22

8.  Comparable Outcomes in Acquired Severe Aplastic Anemia Patients With Haploidentical Donor or Matched Related Donor Transplantation: A Retrospective Single-Center Experience.

Authors:  QingYun Wang; HanYun Ren; ZeYin Liang; Wei Liu; Yue Yin; QingYa Wang; Qian Wang; YuHua Sun; WeiLin Xu; ZhiXiang Qiu; JinPing Ou; Na Han; Jing Wang; YuJun Dong; Yuan Li
Journal:  Front Med (Lausanne)       Date:  2022-01-24

Review 9.  Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Stavroula Masouridi-Levrat; Federico Simonetta; Yves Chalandon
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

10.  Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation.

Authors:  Semra Aydin; Chiara Dellacasa; Sara Manetta; Luisa Giaccone; Laura Godio; Giorgia Iovino; Benedetto Bruno; Alessandro Busca
Journal:  Ther Adv Hematol       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.